Table 1.

Effect of treatment with GH-RH antagonist MZ-4-71 on body and tumor weight, tumor volume, and tumor doubling time in nude mice bearing xenografts of the human kidney adenocarcinoma cell line Caki-I

Treatment group	Tumor volume, mm3		Body weight, g	Tumor weight, mg	Tumor doubling time, days
	Initial	Final
Control	26.5  ±  3.1	504.2  ±  104.1	29.1  ±  0.7	357  ±  118	7.7  ±  0.6
MZ-4-71	24.8  ±  0.9	52.6  ±  12.3**	30.1  ±  0.8	52  ±  18*	59.9  ±  29.6*

Values are mean ± SEM; ∗, P < 0.05 vs. control; ∗∗, P < 0.01 vs. control.